Phio Pharmaceuticals Corp’s recent filing unveils that its President & CEO Bitterman Robert J acquired Company’s shares for reported $740.0 on Jun 07 ’24. In the deal valued at $0.74 per share,1,000 shares were bought. As a result of this transaction, Bitterman Robert J now holds 20,990 shares worth roughly $60661.100000000006.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Bitterman Robert J bought 1,000 shares, generating $750 in total proceeds. Upon buying the shares at $0.75, the President & CEO now owns 19,990 shares.
Before that, Bitterman Robert J bought 2,500 shares. Phio Pharmaceuticals Corp shares valued at $2,275 were divested by the President & CEO at a price of $0.91 per share. As a result of the transaction, Bitterman Robert J now holds 18,990 shares, worth roughly $54881.100000000006.
H.C. Wainwright initiated its Phio Pharmaceuticals Corp [PHIO] rating to a Buy in a research note published on August 05, 2020; the price target was $4.
Price Performance Review of PHIO
On Monday, Phio Pharmaceuticals Corp [NASDAQ:PHIO] saw its stock fall -6.17% to $2.89. Over the last five days, the stock has lost -16.23%. Phio Pharmaceuticals Corp shares have fallen nearly -57.75% since the year began. Nevertheless, the stocks have fallen -78.01% over the past one year. While a 52-week high of $29.07 was reached on 03/06/24, a 52-week low of $2.40 was recorded on 08/08/24. SMA at 50 days reached $3.05, while 200 days put it at $5.63.
Levels Of Support And Resistance For PHIO Stock
The 24-hour chart illustrates a support level at 2.64, which if violated will result in even more drops to 2.38. On the upside, there is a resistance level at 3.16. A further resistance level may holdings at 3.42. The Relative Strength Index (RSI) on the 14-day chart is 38.35, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.33, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.22%. Stochastics %K at 11.48% indicates the stock is a buying.
How much short interest is there in Phio Pharmaceuticals Corp?
A steep rise in short interest was recorded in Phio Pharmaceuticals Corp stocks on 2024-09-13, dropping by 514.0 shares to a total of 17059.0 shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 17573.0 shares. There was a decline of -3.01%, which implies that there is a negative sentiment for the stock.
